124.95
4.79%
5.71
전일 마감가:
$119.24
열려 있는:
$121.84
하루 거래량:
544.43K
Relative Volume:
0.82
시가총액:
$7.41B
수익:
$3.91B
순이익/손실:
$394.92M
주가수익비율:
-79.59
EPS:
-1.57
순현금흐름:
$1.02B
1주 성능:
+0.55%
1개월 성능:
+10.46%
6개월 성능:
+16.81%
1년 성능:
+5.65%
Jazz Pharmaceuticals Plc Stock (JAZZ) Company Profile
명칭
Jazz Pharmaceuticals Plc
전화
353-1-634-7800
주소
FIFTH FLOOR, WATERLOO EXCHANGE, DUBLIN
JAZZ을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
JAZZ | 125.01 | 7.41B | 3.91B | 394.92M | 1.02B | -1.57 |
VRTX | 450.44 | 115.43B | 10.63B | -479.80M | -1.35B | 13.33 |
REGN | 749.43 | 82.04B | 13.85B | 4.65B | 3.32B | 35.06 |
ARGX | 589.59 | 35.30B | 1.86B | -40.29M | -1.28B | -4.16 |
ALNY | 246.53 | 32.04B | 2.09B | -332.26M | 16.06M | -4.14 |
BNTX | 106.84 | 24.89B | 3.30B | -501.07M | 1.03B | 11.54 |
Jazz Pharmaceuticals Plc Stock (JAZZ) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2024-01-03 | 개시 | Robert W. Baird | Outperform |
2023-11-27 | 다운그레이드 | UBS | Buy → Neutral |
2023-09-29 | 개시 | Raymond James | Mkt Perform |
2023-06-12 | 재개 | Wells Fargo | Equal Weight |
2022-12-09 | 업그레이드 | Goldman | Neutral → Buy |
2022-06-14 | 개시 | UBS | Buy |
2022-04-06 | 다운그레이드 | Goldman | Buy → Neutral |
2021-11-19 | 재개 | Goldman | Buy |
2021-10-07 | 재개 | Jefferies | Buy |
2021-10-05 | 개시 | Citigroup | Buy |
2021-09-23 | 개시 | Needham | Buy |
2021-05-19 | 재개 | JP Morgan | Overweight |
2021-04-07 | 재개 | RBC Capital Mkts | Outperform |
2021-02-05 | 재확인 | H.C. Wainwright | Buy |
2021-02-03 | 업그레이드 | Piper Sandler | Neutral → Overweight |
2021-01-29 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
2020-12-16 | 개시 | UBS | Buy |
2020-11-03 | 재확인 | H.C. Wainwright | Buy |
2020-10-09 | 재확인 | H.C. Wainwright | Buy |
2020-09-14 | 다운그레이드 | Goldman | Neutral → Sell |
2020-09-14 | 재개 | JP Morgan | Overweight |
2020-08-06 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
2020-07-28 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
2020-07-23 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
2020-04-06 | 개시 | Jefferies | Buy |
2020-03-12 | 업그레이드 | Bernstein | Mkt Perform → Outperform |
2020-01-08 | 개시 | Goldman | Neutral |
2019-08-21 | 다운그레이드 | Piper Jaffray | Overweight → Neutral |
2019-06-11 | 개시 | Barclays | Overweight |
2019-03-20 | 개시 | SunTrust | Buy |
2018-12-14 | 개시 | Wolfe Research | Peer Perform |
2018-11-08 | 재확인 | B. Riley FBR | Buy |
2018-08-08 | 재확인 | Stifel | Buy |
2018-07-11 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
2018-03-23 | 재확인 | H.C. Wainwright | Neutral |
2018-03-19 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
모두보기
Jazz Pharmaceuticals Plc 주식(JAZZ)의 최신 뉴스
JAZZ Secures FDA Approval For Ziihera In Biliary Tract Cancer - Barchart
U.S. STOCKS Jazz Pharmaceuticals, SPAR, Alphabet - XM
Pacer Advisors Inc. Buys 278,465 Shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - MarketBeat
Thompson Siegel & Walmsley LLC Increases Stock Position in Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - MarketBeat
FDA Greenlights Jazz Pharma's Cancer Drug, A Milestone For Zymework - Benzinga
John G Ullman & Associates Inc. Sells 11,400 Shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - MarketBeat
Jazz Pharmaceuticals stock trades at discount amid diversification efforts By Investing.com - Investing.com UK
Jazz stock Zymeworks stock gain on FDA nod (JAZZ:NASDAQ) - Seeking Alpha
Zymeworks' Ziihera Wins FDA Approval: First Dual HER2 Cancer Drug Shows 52% Response Rate | ZYME Stock News - StockTitan
JAZZ (Jazz Pharmaceuticals) COGS-to-Revenue : 0.11 (As of Sep. 2024) - GuruFocus.com
Jazz Pharmaceuticals receives FDA approval for biliary tract cancer treatment - Reuters.com
Jazz Pharmaceuticals Announces U.S. FDA Approval of Ziihera® (zanidatamab-hrii) for the Treatment of Adults with Previously Treated, Unresectable or Metastatic HER2-positive (IHC 3+) Biliary Tract Cancer (BTC) - JAZZ's Investor Relations
Jazz Pharmaceuticals to Present at Citi's 2024 Global Healthcare Conference | JAZZ Stock News - StockTitan
Should Value Investors Buy Jazz Pharmaceuticals (JAZZ) Stock? - Yahoo Finance
Silver Ring Value Partners: Jazz Pharmaceuticals (JAZZ) Is a “High Uncertainty With Low Risk” Investment - Insider Monkey
Jazz Pharmaceuticals: High Uncertainty, Low Risk (undefined:JAZZ) - Seeking Alpha
Jazz Pharmaceuticals shares target raised on patient base growth By Investing.com - Investing.com UK
Is Jazz Pharmaceuticals plc (JAZZ) the Best Immunotherapy Stock to Buy Now? - Insider Monkey
Jazz Pharmaceuticals (NASDAQ:JAZZ) Given New $162.00 Price Target at Robert W. Baird - MarketBeat
Victory Capital Management Inc. Has $28.22 Million Stock Position in Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - MarketBeat
Jazz Tops Q3 Earnings & Sales Estimates, Raises '24 EPS View - MSN
Los Angeles Capital Management LLC Makes New Investment in Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - MarketBeat
Jazz Pharmaceuticals Plc: Its Efforts Towards Zepzelca Frontline Therapy Expansion & Other Major Drivers - Smartkarma
KBC Group NV Has $25.44 Million Stock Position in Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - MarketBeat
Principal Financial Group Inc. Trims Stock Holdings in Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - MarketBeat
Idiopathic Hypersomnia Treatment Market will experience - openPR
Is the Options Market Predicting a Spike in Jazz (JAZZ) Stock? - Yahoo Finance
We Think Jazz Pharmaceuticals' (NASDAQ:JAZZ) Profit Is Only A Baseline For What They Can Achieve - Simply Wall St
Jazz Pharmaceuticals' (NASDAQ:JAZZ) Performance Is Even Better Than Its Earnings Suggest - Yahoo Finance
Jazz Pharmaceuticals' EVP Neena Patil sells $456,617 in shares By Investing.com - Investing.com Australia
Brokerages Set Jazz Pharmaceuticals plc (NASDAQ:JAZZ) PT at $175.00 - MarketBeat
Jazz Pharmaceuticals' EVP Neena Patil sells $456,617 in shares - Investing.com
Jazz (JAZZ) Upgraded to Buy: Here's Why - Yahoo Finance
JAZZ or CTLT: Which Is the Better Value Stock Right Now? - Yahoo Finance
Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Shares Purchased by Kovack Advisors Inc. - MarketBeat
Wall Street Analysts See a 37.65% Upside in Jazz (JAZZ): Can the Stock Really Move This High? - Yahoo Finance
Is Collegium Pharmaceutical (COLL) a Great Value Stock Right Now? - Yahoo Finance
American Assets Inc. Invests $557,000 in Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - MarketBeat
Jazz Pharmaceuticals Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance
Jazz Pharmaceuticals plc Updates Earnings Guidance for the Full Year 2024 - Marketscreener.com
Jazz (JAZZ) Reliance on International Sales: What Investors Need to Know - Yahoo Finance
28,693 Shares in Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Bought by CWA Asset Management Group LLC - MarketBeat
Amalgamated Bank Sells 9,681 Shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - MarketBeat
Philip James Wealth Mangement LLC Makes New Investment in Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - MarketBeat
Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Q3 2024 Earnings Call Transcript - Insider Monkey
Van ECK Associates Corp Increases Stock Holdings in Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - MarketBeat
Jazz Pharmaceuticals plc (JAZZ) Quarterly 10-Q Report - Quartzy
Jazz Pharma revenues rise 9% in third quarter | Pharmaceutical | The Pharmaletter - The Pharma Letter
Jazz Pharmaceuticals' (JAZZ) "Buy" Rating Reaffirmed at Needham & Company LLC - MarketBeat
Robeco Institutional Asset Management B.V. Sells 19,161 Shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - MarketBeat
Jazz Pharmaceuticals PLC (JAZZ) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and ... - Yahoo Finance
Jazz Pharmaceuticals Plc (JAZZ) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):